AlphaFold predicted structure
CHSY1 · Q86X52

Mean pLDDT
83.4/ 100
Confident
802 residues
Confidence breakdown
- Very high(≥ 90)58%
- Confident(70–90)25%
- Low(50–70)6%
- Very low(< 50)11%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
chondroitin sulfate synthase 1
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Congenital disorders of glycosylation
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalLimb disorders
BIALLELIC, autosomal or pseudoautosomalSkeletal dysplasia
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomalChildhood onset dystonia, chorea or related movement disorder
+3 more panels — install the extension to see the full list inline on any page.
temtamy preaxial brachydactyly syndrome
brachydactyly
hereditary disease
open-angle glaucoma
prostate carcinoma
lumbar disc herniation
palmar fibromatosis
capillary disorder
arterial disorder
musculoskeletal system disorder
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Chondroitin sulfate synthase 1
Catalytic component of CHSY1-CHPF2 and CHSY1-CHPF chondroitin sulfate synthase complexes (PubMed:41298522). Has both beta-1,3-glucuronic acid and beta-1,4-N-acetylgalactosamine transferase activity. Transfers glucuronic acid (GlcUA) from UDP-GlcUA and N-acetylgalactosamine (GalNAc) from UDP-GalNAc to the non-reducing end of the elongating chondroitin polymer (PubMed:11514575, PubMed:12716890). Involved in the negative control of osteogenesis likely through the modulation of NOTCH signaling
CHSY1 · Q86X52

Mean pLDDT
83.4/ 100
Confident
802 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0